A question of disclosure

Psychiatric Services

Volumn 59, Issue 8, 2008, Pages 935-

  Torrey, E Fuller ^a  

^a A Longtime NAMI Member   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CONFLICT OF INTEREST; DRUG COST; DRUG INDUSTRY; LETTER; MENTAL HEALTH SERVICE; SCHIZOPHRENIA; SELF DISCLOSURE;

EID: 50149100705     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.59.8.935     Document Type: Letter

References (3)

1. Duckworth K, Fitzpatrick MJ: NAMI perspective on CATIE: policy and research implications. Psychiatric Services 59:537-539, 2008
2. Rosenheck RA, Leslie DL, Doshi JA: Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making, Psychiatric Services 59:515-520, 2008
3. Lilly Grant Office: Lilly Grant Registry: Disclosure of Grants and Contributions Funded by Eli Lilly and Company. Indianapolis, Ind, Eli Lilly and Co. Available at www.lillygrantoffice.com/grantregistry.jsp